UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 62

Sortiert nach

Detectable Lipidomes and Metabolomes by Different Plasma Exosome Isolation Methods in Healthy Controls and Patients with Advanced Prostate and Lung Cancer

International journal of molecular sciences, 2023-01, Vol.24 (3), p.1830

2023

Volltextzugriff (PDF)

Prevalence of viral DNA in high-grade serous epithelial ovarian cancer and correlation with clinical outcomes

PloS one, 2023-12, Vol.18 (12), p.e0294448-e0294448

2023

Volltextzugriff (PDF)

Utilizing digital pathology to quantify stromal caveolin-1 expression in malignant and benign ovarian tumors: Associations with clinicopathological parameters and clinical outcomes

PloS one, 2021-11, Vol.16 (11), p.e0256615-e0256615

2021

Volltextzugriff (PDF)

Metabolic vulnerabilities in endometrial cancer

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (20), p.5832-5845

2014

Volltextzugriff (PDF)

Pan-cancer analysis reveals TAp63-regulated oncogenic lncRNAs that promote cancer progression through AKT activation

Nature communications, 2020-10, Vol.11 (1), p.5156-5156, Article 5156

2020

Volltextzugriff (PDF)

Analysis of Chemotherapeutic Response in Ovarian Cancers Using Publicly Available High-Throughput Data

Cancer research (Chicago, Ill.), 2014-07, Vol.74 (14), p.3902-3912

2014

Volltextzugriff (PDF)

Valproic acid alters chromatin structure by regulation of chromatin modulation proteins

Cancer research (Chicago, Ill.), 2005-05, Vol.65 (9), p.3815-3822

2005

Volltextzugriff (PDF)

Human Multiple Myeloma Cells Are Sensitized to Topoisomerase II Inhibitors by CRM1 Inhibition

Cancer research (Chicago, Ill.), 2009-09, Vol.69 (17), p.6899-6905

2009

Volltextzugriff (PDF)

ERBB4 Expression in Ovarian Serous Carcinoma Resistant to Platinum-Based Therapy

Cancer control, 2017-01, Vol.24 (1), p.89-95

2017

Volltextzugriff (PDF)

Selective Inhibition of Histone Deacetylase 2 Silences Progesterone Receptor-Mediated Signaling

Cancer research (Chicago, Ill.), 2008-03, Vol.68 (5), p.1513-1519

2008

Volltextzugriff (PDF)

Sequence-specific potentiation of topoisomerase II inhibitors by the histone deacetylase inhibitor suberoylanilide hydroxamic acid

Journal of cellular biochemistry, 2004-05, Vol.92 (2), p.223-237

2004

Volltextzugriff (PDF)

The Chinese herb polyphyllin D sensitizes ovarian cancer cells to cisplatin-induced growth arrest

Journal of cancer research and clinical oncology, 2015-02, Vol.141 (2), p.237-242

2015

Volltextzugriff (PDF)

HDAC2 regulates chromatin plasticity and enhances DNA vulnerability

Molecular cancer therapeutics, 2009-04, Vol.8 (4), p.794-801

2009

Volltextzugriff (PDF)

Gene expression data reveal common pathways that characterize the unifocal nature of ovarian cancer

American journal of obstetrics and gynecology, 2013-12, Vol.209 (6), p.576.e1-576.e16

2013

Volltextzugriff (PDF)

In vivo synergy between topoisomerase II and histone deacetylase inhibitors: predictive correlates

Molecular cancer therapeutics, 2005-12, Vol.4 (12), p.1993-2000

2005

Volltextzugriff (PDF)

Perifosine, an AKT inhibitor, modulates ovarian cancer cell line sensitivity to cisplatin-induced growth arrest

Gynecologic oncology, 2013-10, Vol.131 (1), p.207-212

2013

Volltextzugriff (PDF)

Synergistic Interaction between Histone Deacetylase and Topoisomerase II Inhibitors Is Mediated through Topoisomerase IIβ

Clinical cancer research, 2005-12, Vol.11 (23), p.8467-8475

2005

Volltextzugriff (PDF)

Addition of a histone deacetylase inhibitor redirects tamoxifen-treated breast cancer cells into apoptosis, which is opposed by the induction of autophagy

Breast cancer research and treatment, 2011-11, Vol.130 (2), p.437-447

2011

Volltextzugriff (PDF)

Expression of the BAD pathway is a marker of triple-negative status and poor outcome

Scientific reports, 2019-11, Vol.9 (1), p.17496-14, Article 17496

2019

Volltextzugriff (PDF)

BAD Phosphorylation Determines Ovarian Cancer Chemosensitivity and Patient Survival

Clinical cancer research, 2011-10, Vol.17 (19), p.6356-6366

2011

Volltextzugriff (PDF)

BCL2 antagonist of cell death kinases, phosphatases, and ovarian cancer sensitivity to cisplatin

Journal of Gynecologic Oncology, 2012, 23(1), , pp.35-42

2012

Volltextzugriff (PDF)

BAD-mediated apoptotic pathway is associated with human cancer development

International journal of molecular medicine, 2015-04, Vol.35 (4), p.1081-1087

2015

Volltextzugriff (PDF)

Micro-RNAs associated with the evolution of ovarian cancer cisplatin resistance

Gynecologic oncology, 2016-02, Vol.140 (2), p.259-263

2016

Volltextzugriff (PDF)

Degradation of HER2 by ansamycins induces growth arrest and apoptosis in cells with HER2 overexpression via a HER3, phosphatidylinositol 3'-kinase-AKT-dependent pathway

Cancer research (Chicago, Ill.), 2002-06, Vol.62 (11), p.3132-3137

2002

Volltextzugriff (PDF)

Prediction of Optimal Cytoreductive Surgery of Serous Ovarian Cancer With Gene Expression Data

International journal of gynecological cancer, 2015-07, Vol.25 (6), p.1000-1009

2015

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(60)
Dissertationen
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(43)
Life Sciences & Biomedicine
(36)
Humans
(34)
Oncology
(27)
Female
(26)
Cell Line, Tumor
(18)
Ovarian Cancer
(17)
Animals
(14)
Tumors
(13)
Biological And Medical Sciences
(12)
Gene Expression
(12)
Ovarian Neoplasms - Genetics
(12)
Signal Transduction
(12)
Medical Sciences
(11)
Ovarian Neoplasms - Drug Therapy
(11)
Ovarian Neoplasms - Metabolism
(9)
Ovarian Neoplasms - Pathology
(9)
Antineoplastic Agents
(8)
Oligonucleotide Array Sequence Analysis
(8)
Pharmacology. Drug Treatments
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Detectable Lipidomes and Metabolomes by Different Plasma Exosome Isolation Methods in Healthy Controls and Patients with Advanced Prostate and Lung Cancer

Prevalence of viral DNA in high-grade serous epithelial ovarian cancer and correlation with clinical outcomes

Utilizing digital pathology to quantify stromal caveolin-1 expression in malignant and benign ovarian tumors: Associations with clinicopathological parameters and clinical outcomes

Metabolic vulnerabilities in endometrial cancer

Pan-cancer analysis reveals TAp63-regulated oncogenic lncRNAs that promote cancer progression through AKT activation

Analysis of Chemotherapeutic Response in Ovarian Cancers Using Publicly Available High-Throughput Data

Valproic acid alters chromatin structure by regulation of chromatin modulation proteins

Human Multiple Myeloma Cells Are Sensitized to Topoisomerase II Inhibitors by CRM1 Inhibition

ERBB4 Expression in Ovarian Serous Carcinoma Resistant to Platinum-Based Therapy

Selective Inhibition of Histone Deacetylase 2 Silences Progesterone Receptor-Mediated Signaling

Sequence-specific potentiation of topoisomerase II inhibitors by the histone deacetylase inhibitor suberoylanilide hydroxamic acid

The Chinese herb polyphyllin D sensitizes ovarian cancer cells to cisplatin-induced growth arrest

HDAC2 regulates chromatin plasticity and enhances DNA vulnerability

Gene expression data reveal common pathways that characterize the unifocal nature of ovarian cancer

In vivo synergy between topoisomerase II and histone deacetylase inhibitors: predictive correlates

Perifosine, an AKT inhibitor, modulates ovarian cancer cell line sensitivity to cisplatin-induced growth arrest

Synergistic Interaction between Histone Deacetylase and Topoisomerase II Inhibitors Is Mediated through Topoisomerase IIβ

Addition of a histone deacetylase inhibitor redirects tamoxifen-treated breast cancer cells into apoptosis, which is opposed by the induction of autophagy

Expression of the BAD pathway is a marker of triple-negative status and poor outcome

BAD Phosphorylation Determines Ovarian Cancer Chemosensitivity and Patient Survival

BCL2 antagonist of cell death kinases, phosphatases, and ovarian cancer sensitivity to cisplatin

BAD-mediated apoptotic pathway is associated with human cancer development

Micro-RNAs associated with the evolution of ovarian cancer cisplatin resistance

Degradation of HER2 by ansamycins induces growth arrest and apoptosis in cells with HER2 overexpression via a HER3, phosphatidylinositol 3'-kinase-AKT-dependent pathway

Prediction of Optimal Cytoreductive Surgery of Serous Ovarian Cancer With Gene Expression Data

Suchergebnisse filtern